•
Mar 31, 2018

Jazz Pharmaceuticals Q1 2018 Earnings Report

Total Revenue
$445M
Previous year: $376M
+18.2%
EPS
$2.98
Previous year: $2.31
+29.0%
Gross Profit
$411M
Previous year: $351M
+17.0%
Cash and Equivalents
$453M
Previous year: $347M
+30.6%
Total Assets
$5.29B
Previous year: $4.82B
+9.8%

Jazz Pharmaceuticals

Jazz Pharmaceuticals